Bracco Imaging announces global agreement with Subtle Medical
Industry Leaders to Explore the Potential of AI in Contrast-Enhanced MRI
Bracco Imaging S.p.A., a global leader in diagnostic imaging, and Subtle Medical, Inc., a leading innovator in artificial intelligence (AI)-powered image acquisition, have entered into a global agreement in the field of magnetic resonance imaging (MRI). This global agreement will begin primarily in the United States, where Bracco Imaging distributes its portfolio of products and services through its subsidiary, Bracco Diagnostics Inc.
Contrast-enhanced MRI involves the use of contrast agents to highlight specific tissues or abnormalities, providing better visualization and more detailed information. Exploring and harnessing the power of AI in this context could lead to more accurate and efficient image interpretation, enhanced diagnostic capabilities, and optimized patient care. Through this strategic partnership, Bracco Imaging and Subtle Medical can leverage mutual intellectual property to make progress toward achieving these ambitious goals.
“The combination of Bracco’s expertise in contrast imaging and Subtle Medical’s deep-learning technology, when applied to MR imaging, will undoubtedly benefit physicians and their patients,” said Fulvio Renoldi Bracco, Vice Chairman & Chief Executive Officer of Bracco Imaging S.p.A. “Through this partnership, we will strive to redefine the boundaries of diagnostic precision and efficiency, unlocking new possibilities and bringing additional value to our already-unique MRI portfolio.”
“Subtle Medical is pleased to partner with a global leader in contrast development and commercialization such as Bracco,” said Enhao Gong, Chief Executive Officer of Subtle Medical, Inc. “This agreement represents a significant milestone for both companies, as we join forces to empower medical professionals and improve outcomes for patients worldwide with Subtle Medical’s platform and innovative suite of AI products for MRI and beyond.”